share_log
Reuters ·  04/30 06:30

Immunic Announces Publication of Extended Data From Phase 2 Emphasis Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation

Immunic宣布在同行评审期刊《神经病学® 神经免疫学与神经炎症》上发布Vidofludimus钙治疗复发缓解型多发性硬化症的2期重点试验的扩展数据

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发